<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pulmonary tuberculosis: Clinical manifestations and complications</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pulmonary tuberculosis: Clinical manifestations and complications</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pulmonary tuberculosis: Clinical manifestations and complications</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anton Pozniak, MD, FRCP</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John Bernardo, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nestor L Muller, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 04, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The lungs are the major site for <em>Mycobacterium tuberculosis</em> infection and tuberculosis (TB) disease. The natural history, clinical manifestations, and complications of pulmonary TB disease will be reviewed here. The epidemiology, pathogenesis, diagnosis, and treatment of pulmonary TB disease are discussed separately, as are extrapulmonary and miliary TB. (See related topics.)</p><p class="headingAnchor" id="H3923589494"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>TB terminology is inconsistent in the literature [<a href="#rid1">1</a>]. Relevant terms are defined in the table  (<a class="graphic graphic_table graphicRef132526" href="/d/graphic/132526.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H1528649"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H4039217201"><span class="h2">Natural history</span><span class="headingEndMark"> — </span>Most commonly, TB is transmitted via aerosol droplets generated when a person with the disease involving the lungs or airways coughs or sneezes. Inhalation of aerosolized droplets containing <em>M. tuberculosis</em> by a susceptible, previously uninfected individual leads to deposition in the lungs, with one of the following possible outcomes:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immediate clearance of the organism</strong> – Immediate clearance refers to inhalation, containment, and clearance of M. tuberculosis is inhaled before an adaptive response develops [<a href="#rid2">2</a>]. In one study including 66 sailors who shared a ship cabin with seven others who had pulmonary TB, 13 of the 66 had negative <a class="drug drug_general" data-topicid="10029" href="/d/drug information/10029.html" rel="external">tuberculin skin test</a> results six months later, suggesting early clearance of the organisms [<a href="#rid3">3</a>].<em> </em></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>TB infection (previously termed latent TB) </strong>– TB infection refers to containment of viable organisms via host immunity. In patients with TB infection, there is evidence of specific cell-mediated immunologic response following exposure to <em>Mycobacterium tuberculosis</em>-derived protein antigens in solution (eg, positive TST and/or IGRA), in the absence of signs or symptoms of illness. </p><p></p><p class="bulletIndent1">Following<em> M. tuberculosis</em> exposure, TB infection occurs in 90 percent of individuals with intact immunity. Worldwide, approximately two to three billion people have TB infection.</p><p></p><p class="bulletIndent1">Innate and adaptive immune cells are involved in trying to control and eliminate <em>M. tuberculosis</em>; the host genetic susceptibility and the virulence of the pathogen also play important roles. Tuberculous bacilli proliferate inside alveolar macrophages; following a complex immunological response with production of cytokines to attract other phagocytic cells (including monocytes and neutrophils), a nodular granulomatous structure (tubercle) forms [<a href="#rid4">4</a>]. Radiologically this may be observed as a Ghon focus.</p><p></p><p class="bulletIndent1">Subsequently, the tubercle enlarges and bacilli enter the lymphatic drainage system, leading to lymphangitis and enlarged regional lymph nodes. Radiologically, a Ghon focus observed in conjunction with lymphadenopathy is referred to as a Ghon complex [<a href="#rid5">5,6</a>]. A Ghon complex that has undergone calcification is referred to as a Ranke complex [<a href="#rid5">5,7</a>]. The Ghon lesion and Ghon complex can be observed with TB infection and primary TB disease. Calcification occurs later during the healing phase.</p><p></p><p class="bulletIndent1">The bacilli continue proliferating until an effective cell-mediated immune (CMI) response develops, usually 2 to 10 weeks following initial infection in more than 90 percent of individuals. A successful CMI contains viable organisms at sites where they migrated prior to successful sensitization. Individuals who mount a successful CMI have TB infection. Individuals who fail to mount a successful CMI progress to primary TB disease (described further below).</p><p></p><p class="bulletIndent1">The host immune response includes activation of several pathways targeting the bacilli (including activation of tumor necrosis factor (TNF)-alpha, reactive oxygen and nitrogen intermediates, and cytotoxic cells); this inflammatory response may also contribute to collateral host cell damage and the development of caseating (cheese-like) necrosis. Caseous necrosis is frequently associated with TB but can also be caused by other organisms (including syphilis, histoplasmosis, cryptococcosis, and coccidioidomycosis; see related topics).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Reactivation disease (or postprimary TB)</strong> – Reactivation disease and postprimary TB are often used interchangeably to describe occurrence of TB after a period of clinical latency. </p><p></p><p class="bulletIndent2">Among individuals with no underlying medical problems, the lifetime risk of reactivation disease is 5 to 10 percent, with a 5 percent risk in the two to five years following infection and another 5 percent risk over the remaining lifetime [<a href="#rid8">8-10</a>]. Therefore, it has been proposed that treatment of TB infection be prioritized for those who are recently infected.</p><p></p><p class="bulletIndent2">Some immunosuppressive conditions associated with increased risk for reactivation TB disease include HIV infection, organ transplantation, silicosis, use of immunosuppressive agents (including corticosteroids and tumor necrosis factor-alpha blockers), diabetes, and chronic kidney disease [<a href="#rid11">11-14</a>].</p><p></p><p class="bulletIndent2">The disease process in reactivation TB tends to be localized (in contrast with primary TB disease); in general, there is little regional lymph node involvement and less caseation. The lesion typically occurs at the lung apices, and disseminated disease is unusual unless the host is severely immunosuppressed.</p><p></p><p class="bulletIndent2">Prior TB infection, contained by the host immune response, confers some protection against subsequent TB disease [<a href="#rid15">15</a>]. One review evaluating 23 paired cohorts (total more than 19,000 individuals) noted that individuals with TB infection had 79 percent lower risk of progressive TB following reinfection compared with uninfected individuals [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Primary TB disease</strong> – Primary TB refers to immediate onset of TB disease following <em>M. tuberculosis</em> exposure in a previously naïve host. (See <a class="local">'Primary tuberculosis'</a> below.)</p><p></p><p class="bulletIndent1">Failure of the host to mount an effective CMI response leads to progressive tissue destruction, manifesting as symptomatic primary TB disease. Bacilli may migrate away from the lungs (via the bloodstream and lymphatics) to enter other tissues, producing disseminated TB. If caseating lesions erode into the airways, the host becomes infectious to others. </p><p></p><p class="bulletIndent1">Primary TB was considered to be mainly a disease of childhood until the introduction of effective antituberculous treatment with <a class="drug drug_general" data-topicid="8577" href="/d/drug information/8577.html" rel="external">isoniazid</a> in the 1950s. Since that time, many studies have shown an increased frequency of primary TB disease among adolescents and adults, particularly individuals with some forms of immunosuppression (such as HIV infection or TNF-alpha inhibitor treatment) [<a href="#rid17">17,18</a>].</p><p></p><p class="headingAnchor" id="H2"><span class="h2">Primary tuberculosis</span><span class="headingEndMark"> — </span>Primary TB disease is defined above. (See <a class="local">'Natural history'</a> above.)</p><p class="headingAnchor" id="H3"><span class="h3">Symptoms and signs</span><span class="headingEndMark"> — </span>The natural history of primary TB was well described in a prospective study of 517 new tuberculin converters living on the Faroe Islands off the coast of Norway from 1932 to 1946 [<a href="#rid19">19</a>]. The study included 331 adults and 186 children; all were followed for more than five years. The clinical manifestations of primary TB varied substantially in this population, and symptoms and signs referable to the lungs were present in approximately one-third of patients. Fever was the most common symptom, occurring in 70 percent of 232 patients in whom fever was not a condition for enrollment in the study. The fever onset was generally gradual and low grade but could be as high as 39°C (102.2°F) and lasted for an average of 14 to 21 days. Fever resolved in 98 percent of patients by 10 weeks.</p><p>Fever was not usually accompanied by other symptoms, although approximately 25 percent of patients developed pleuritic or retrosternal pain. One-half of patients with pleuritic chest pain had evidence of a pleural effusion. Retrosternal and dull interscapular pain were ascribed to enlarged bronchial lymph nodes and sometimes worsened with swallowing. Rarer symptoms included fatigue, cough, arthralgia, and pharyngitis. (See  <a class="medical medical_review" href="/d/html/8012.html" rel="external">"Tuberculous pleural effusion"</a>.)</p><p class="headingAnchor" id="H4"><span class="h3">Radiologic findings</span></p><p class="headingAnchor" id="H772365382"><span class="h4">Chest radiography</span><span class="headingEndMark"> — </span>In primary pulmonary TB, the chest radiograph is often normal. Common radiographic manifestations include hilar and/or mediastinal lymphadenopathy  (<a class="graphic graphic_diagnosticimage graphicRef134475" href="/d/graphic/134475.html" rel="external">image 1</a>), pleural effusion, and pulmonary consolidation. The consolidation in primary TB may be segmental or lobar, may involve any lobe, and is typically homogeneous  (<a class="graphic graphic_diagnosticimage graphicRef134476" href="/d/graphic/134476.html" rel="external">image 2</a>) [<a href="#rid5">5</a>]. In one series including 517 patents with recent skin test conversion, chest radiograph findings were notable for the following [<a href="#rid19">19</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Hilar lymphadenopathy was the most common finding, occurring in 65 percent of cases. Hilar changes were visible early as one week after skin test conversion, and within two months in all cases.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pleural effusions developed in approximately one-third of patients, typically within the first three to four months after infection but occasionally as late as one year.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary consolidation was observed in 27 percent of patients; in general, it resolved slowly, over months to years.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Perihilar and right-sided consolidation was the most common, and ipsilateral hilar enlargement was the rule.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Contralateral hilar changes sometimes were present; only 2 percent of patients had bilateral consolidation.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lower and upper lobe consolidation was observed in 33 and 13 percent of patients, respectively; 43 percent of adults with consolidation also had effusions.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The areas of consolidation progressed within the first year after skin test conversion in 20 patients (15 percent of cases), reflecting progressive primary TB. The majority of these patients had progression of disease at the original site; four developed cavitation.</p><p></p><p>Other studies that provide insight into the clinical manifestations of TB have focused retrospectively upon patients with culture-proven TB [<a href="#rid20">20-22</a>]. In one series from Canada, 188 patients were assessed, all of whom were culture positive and had abnormal chest radiographs [<a href="#rid21">21</a>]. Thirty patients (18 percent) were classified clinically as having primary TB. The most common finding was lymphadenopathy, most commonly unilateral hilar or hilar and mediastinal, present in 67 percent. Right middle lobe collapse may complicate the lymphadenopathy but usually resolves with therapy.</p><p>Several factors probably favor development of atelectasis of the right middle lobe (RML). The RML bronchus is more densely surrounded by lymph nodes, it has a relatively longer length and smaller internal caliber, and it has a sharper branching angle.</p><p>In this retrospective series, pleural effusions were present in 33 percent and were the sole abnormality in 23 percent of cases [<a href="#rid21">21</a>]. Pulmonary parenchymal involvement was present in 63 percent of patients and the consolidation involved primarily the upper lobes. Two patients had cavitation and two others had evidence of endobronchial spread. In another study, pulmonary consolidation occurred in 17 of 34 patients (50 percent) and it involved the mid and lower regions of the lungs slightly more often than the upper lung zones [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H1718076310"><span class="h4">Computed tomography</span><span class="headingEndMark"> — </span>Contrast enhanced computed tomography (CT) may demonstrate a number of findings [<a href="#rid24">24,25</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Enlarged hilar and/or mediastinal lymph nodes which frequently demonstrate central low attenuation (reflecting caseous necrosis) and peripheral rim enhancement  (<a class="graphic graphic_diagnosticimage graphicRef134476" href="/d/graphic/134476.html" rel="external">image 2</a>). Rarely, lymphadenopathy may cause bronchial compression and/or airway compromise </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In primary TB, consolidation is usually dense and homogeneous; predominance in the lower and middle lobes (subpleural sites) is suggestive of the disease, especially in adults [<a href="#rid5">5</a>]. It may also be patchy, nodular, or mass-like. Parenchymal opacification may demonstrate a "<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fradiopaedia.org%2Farticles%2Fgalaxy-sign-lungs%3Flang%3Dgb&amp;token=nQg4nLtWJiX5lr0J3kejPzsN0yArI5IhmMmxQx8gqfKu2myUL7pXK8gLRHBmlULQOOGPGnSplF2y9bthIKaZGK8AtSQsFLDSFqHlsS1NKKs%3D&amp;TOPIC_ID=7026" target="_blank">galaxy sign</a>," a mass-like region composed of numerous smaller granulomas. The appearance of a central core with peripheral nodules is reminiscent of a globular cluster or galaxy [<a href="#rid26">26</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Miliary changes. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Solitary cavities can occur in up to 10 percent of patients. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pleural effusions occur in about 10 percent of adults with primary TB; they are usually unilateral, on the same side as the primary focus. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rarer manifestations in adults include large masses and spontaneous pneumothorax. Tracheobronchial stenoses, mediastinitis, and even mediastinal abscesses may be observed.</p><p></p><p>In approximately two-thirds of cases, the parenchymal focus resolves without sequelae on radiography but this can take up to two years. In the remaining cases, a radiologic scar persists that can calcify in up to 15 percent of cases. Persistent mass like opacities "tuberculomas" are seen in approximately 10 percent of cases [<a href="#rid5">5</a>]. </p><p class="headingAnchor" id="H1478574522"><span class="h2">Reactivation (postprimary) tuberculosis</span></p><p class="headingAnchor" id="H6"><span class="h3">Symptoms</span></p><p class="headingAnchor" id="H3353589316"><span class="h4">General principles</span><span class="headingEndMark"> — </span>Reactivation disease is defined above. (See <a class="local">'Natural history'</a> above.)</p><p>The symptoms of reactivation TB have been described retrospectively, mainly in case series of hospitalized patients in single institutions [<a href="#rid27">27-29</a>]. In these series, symptoms typically began insidiously and were present for weeks or months before the diagnosis was made. One-half to two-thirds of patients developed cough, weight loss, and fatigue. Fever and night sweats or night sweats alone were present in approximately one-half. Chest pain and dyspnea each were reported in approximately one-third of patients and hemoptysis in approximately one-quarter. Many patients had vague or nonspecific symptoms; almost one-third of patients had pulmonary TB diagnosed after an admission for unrelated complaints [<a href="#rid27">27</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>Fever is usually low grade at onset but becomes marked with progression of disease. It is classically diurnal, with an afebrile period early in the morning and a gradually rising temperature throughout the day, reaching a peak in the late afternoon or evening. Fever subsides during sleep, but night sweats may occur. Fever and night sweats are more common among patients with advanced pulmonary TB [<a href="#rid30">30</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cough may be absent or mild initially and may be nonproductive or productive of only scant sputum. Initially, it may be present only in the morning, when accumulated secretions during sleep are expectorated. As the disease progresses, cough becomes more continuous throughout the day and productive of yellow or yellow-green and occasionally blood-streaked sputum, which is rarely foul smelling. Symptomatic individuals are more likely to have smear-positive sputum [<a href="#rid31">31</a>]. Frank hemoptysis, due to caseous sloughing or endobronchial erosion, typically occurs later in the disease and is rarely massive. Nocturnal coughing is associated with advanced disease, often with cavitation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dyspnea can occur in the setting of extensive parenchymal involvement, pleural effusions, or a pneumothorax. Pleuritic chest pain is not common but, when present, signifies inflammation abutting or invading the pleura, with or without an effusion. Rarely, this can progress to frank empyema.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the absence of treatment, patients may present with painful ulcers of the mouth, tongue, larynx, or gastrointestinal tract due to chronic expectoration and swallowing of highly infectious secretions; these findings are rare in the setting of antituberculous therapy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anorexia, wasting (consumption), and malaise are common features of advanced disease and may be the only presenting features in some patients.</p><p></p><p>Ambulatory patients with TB disease typically have milder and less specific symptoms than hospitalized patients. In a study including 313 TB cases identified among ambulatory patients, cough &gt;2 weeks was observed among 52 percent of patients with pulmonary disease; fever &gt;2 weeks was observed among 29 percent of patients [<a href="#rid32">32</a>]. In addition, clinical symptoms were observed less frequently among patients of Asian ethnicity than among other patients.</p><p>Many patients experience multiple missed diagnostic opportunities prior to diagnosis, with around 75 percent of experiencing at least one missed opportunity. Risk factors for delays included outpatient or emergency department settings, weekend visits, patient age, influenza season presentation, history of chronic respiratory symptoms and prior fluoroquinolone use [<a href="#rid33">33</a>]. </p><p>Other comorbidities may affect the presentation of TB reactivation; these include diabetes, administration of immunosuppressive drugs such as tumor necrosis factor (TNF)-alpha inhibitors, chronic renal disease, and advanced HIV infection. Such patients present with more symptoms and a higher proportion of smear positivity, cavitation, treatment failure, and non-TB deaths [<a href="#rid34">34</a>]. (See  <a class="medical medical_review" href="/d/html/1411.html" rel="external">"Risk of mycobacterial infection associated with biologic agents and JAK inhibitors"</a> and  <a class="medical medical_review" href="/d/html/111683.html" rel="external">"Diagnosis of pulmonary tuberculosis in adults"</a>.)</p><p>Diagnosis of tuberculosis after recovering from COVID-19 has been described [<a href="#rid35">35</a>]. Contributing factors may include the immunosuppressive nature of COVID-19 infection as well as treatment with corticosteroids. Some patients have developed TB several months after COVID-19 recovery [<a href="#rid35">35</a>]. </p><p class="headingAnchor" id="H7"><span class="h4">Presentation in older adults</span><span class="headingEndMark"> — </span>In nonendemic countries, the incidence of pulmonary TB is two to three times higher among older adults, especially those in old age homes, and the risk of death is higher compared with younger patients [<a href="#rid36">36,37</a>].</p><p>Comparative studies have suggested some differences in the manifestations of pulmonary TB between older and younger patients. A meta-analysis including 12 studies noted no significant differences between patients &gt;60 years and patients &lt;60 years with respect to time to diagnosis, prevalence of cough, sputum production, weight loss, or fatigue/malaise [<a href="#rid38">38</a>]. Findings observed less commonly among older adults included fever, sweats, hemoptysis, cavitary disease, and a positive <a class="drug drug_general" data-topicid="10029" href="/d/drug information/10029.html" rel="external">tuberculin skin test</a>, but they were likely to present with the nonspecific symptoms of dyspnea and fatigue. Findings observed more frequently among older adults included hypoalbuminemia, leukopenia, and underlying disorders such as cardiovascular disease, chronic obstructive pulmonary disease (COPD), diabetes, malignancy, and gastrectomy. Cavitary disease is less common, and multilobar and lower lobe involvement more common. Because of comorbidities such as COPD and the nonspecificity of symptoms, the diagnosis in older adults can be delayed or missed [<a href="#rid39">39,40</a>].</p><p class="headingAnchor" id="H8"><span class="h3">Physical findings</span><span class="headingEndMark"> — </span>Physical findings of pulmonary TB are not specific and usually are absent in mild or moderate disease. Dullness with decreased fremitus may indicate pleural thickening or effusion. Crackles may be present throughout inspiration or may be heard only after a short cough (posttussive crackles). When large areas of the lung are involved, signs of consolidation associated with open bronchi, such as whispered pectoriloquy or tubular breath sounds, may be heard. Distant hollow breath sounds over cavities are called amphoric, after the sound made by blowing across the mouth of jars used in antiquity (amphorae). Extrapulmonary signs include clubbing and findings localized to other sites of involvement. (See  <a class="medical medical_review" href="/d/html/8024.html" rel="external">"Clinical manifestations, diagnosis, and treatment of miliary tuberculosis"</a>.)</p><p class="headingAnchor" id="H9"><span class="h3">Laboratory findings</span><span class="headingEndMark"> — </span>The approach to diagnosis of TB is discussed separately. (See  <a class="medical medical_review" href="/d/html/111683.html" rel="external">"Diagnosis of pulmonary tuberculosis in adults"</a>.)</p><p>Routine hematology and biochemistry laboratory studies are frequently normal in the setting of pulmonary TB. The C-reactive protein (CRP) can be elevated in up to 85 percent of patients [<a href="#rid41">41</a>]. Late in the disease, hematologic changes may include normocytic anemia, leukocytosis, or, more rarely, monocytosis. Hyponatremia may be associated with the syndrome of inappropriate antidiuretic hormone secretion (SIADH) [<a href="#rid42">42</a>] or rarely with adrenal insufficiency. Hypoalbuminemia and hypergammaglobulinemia also can occur as late findings.</p><p class="headingAnchor" id="H10"><span class="h3">Radiologic findings</span><span class="headingEndMark"> — </span>Most patients with reactivation TB have abnormalities on chest radiography, even in the absence of respiratory symptoms [<a href="#rid27">27,43</a>]. Reactivation TB typically involves the apical and posterior segments of the upper lobes (80 to 90 percent of patients  (<a class="graphic graphic_diagnosticimage graphicRef134478" href="/d/graphic/134478.html" rel="external">image 3</a>)), followed in frequency by the superior segment of the lower lobes and the anterior segment of the upper lobes [<a href="#rid27">27,44-46</a>]. The most common and typical manifestation consists of patchy heterogeneous areas of consolidation with poorly defined margins [<a href="#rid5">5,47</a>]. In multiple large series of TB among adults, 70 to 87 percent had upper lobe consolidation typical of postprimary disease; 19 to 40 percent also had cavities, with visible air-fluid levels in as many as 20 percent of cases [<a href="#rid27">27,44-46</a>].</p><p>Adults without upper lobe consolidation or cavitation have "atypical" radiologic patterns (13 to 30 percent of pulmonary TB cases) [<a href="#rid20">20,23,48</a>]. These findings include hilar lymphadenopathy (sometimes associated with right middle lobe atelectasis), consolidation or cavities in the middle or lower lung zones, pleural effusions, and solitary nodules. These "atypical" findings are more common in the setting of primary TB and, at least in some cases, probably represent increasing incidence of primary TB rather than "atypical" forms of reactivation TB. (See <a class="local">'Primary tuberculosis'</a> above.)</p><p>Up to 5 percent of patients with TB disease present with upper lobe fibrocalcific opacities thought to be indicative of healed primary TB. However, such patients should be evaluated for TB disease in the setting of pulmonary symptoms or absence of serial radiographs documenting stability of the lesion.</p><p>A normal chest radiograph is also possible even in pulmonary TB disease. As an example, in one Canadian study of 518 patients with culture-proven pulmonary TB, 25 patients (5 percent) had normal chest radiographs; 23 of these patients had pulmonary symptoms at the time of the normal radiograph [<a href="#rid49">49</a>]. In this series conducted over a 10-year period, normal chest radiographs represented less than 1 percent of the radiographs in 1988 to 1989 but increased to 10 percent from 1996 to 1997.</p><p>CT scanning is more sensitive and specific than chest radiography for diagnosis, particularly for smaller lesions located in the apex of the lung  (<a class="graphic graphic_diagnosticimage graphicRef134478" href="/d/graphic/134478.html" rel="external">image 3</a>) [<a href="#rid50">50,51</a>]. Chest CT is useful in patients with suspected pulmonary TB and normal or nonspecific abnormalities on chest radiograph [<a href="#rid51">51</a>]. CT scans typically demonstrate more lesions than are visible on the chest radiograph and are particularly helpful in detecting hilar or mediastinal lymphadenopathy.</p><p>Chest CT may also demonstrate apicoposterior consolidation, cavities, pleural effusions, fibrotic lesions causing distortion of lung parenchyma, elevation of fissures and hila, pleural thickening and calcification, small effusions, and formation of traction bronchiectasis. Lymphadenopathy occurs only in 5 percent of cases. Chest wall involvement, due to direct extension from pulmonary disease, can be seen as bone and/or cartilage destruction and cutaneous fistula formation. High-resolution CT is the imaging technique of choice to detect early bronchogenic spread. The most common findings consist of centrilobular 2 to 4 mm nodules and branching linear or nodular opacities referred to as "tree-in-bud" pattern representing intrabronchiolar and peribronchiolar caseation necrosis  (<a class="graphic graphic_diagnosticimage graphicRef134479" href="/d/graphic/134479.html" rel="external">image 4</a> and <a class="graphic graphic_diagnosticimage graphicRef134480" href="/d/graphic/134480.html" rel="external">image 5</a>) [<a href="#rid52">52</a>].</p><p>Radiologic findings in the setting of pulmonary TB are discussed further separately. (See  <a class="medical medical_review" href="/d/html/111683.html" rel="external">"Diagnosis of pulmonary tuberculosis in adults"</a>.)</p><p class="headingAnchor" id="H472730128"><span class="h2">Other manifestations</span></p><p class="headingAnchor" id="H11"><span class="h3">Endobronchial tuberculosis</span><span class="headingEndMark"> — </span>Endobronchial TB is defined as tuberculous disease that involves the tracheobronchial tree. It may develop via direct extension to the bronchi from an adjacent parenchymal focus (usually a cavity) or via spread of organisms to the bronchi via infected sputum. Lesions are more likely to be observed in the main and upper bronchi; in 5 percent of patients, the lower trachea is involved [<a href="#rid53">53</a>].</p><p>Prior to the availability of antituberculous therapy, endobronchial TB was relatively common in the setting of primary infection and reactivation TB [<a href="#rid54">54-57</a>]. In a 1943 study in a TB sanatorium in West Virginia, lesions in the tracheobronchial tree were observed in 15 percent of cases via rigid bronchoscopy and in 40 percent of cases at autopsy [<a href="#rid54">54</a>]. Endobronchial disease was observed more frequently among patients with extensive pulmonary TB, particularly cavitary lesions. Upper lung parenchymal or cavitary disease with bronchogenic spread to the lower lobes was commonly observed, presumably from pooled infected secretions. Endobronchial TB appears to have a preponderance in females in their second and third decades of life [<a href="#rid19">19,20</a>] and in the older adult population (mean age 70 years) [<a href="#rid21">21,58</a>].</p><p>Since the availability of antituberculous therapy, endobronchial TB has been described in 6 to 54 percent of patients with pulmonary TB disease [<a href="#rid59">59-62</a>]. Some degree of bronchial stenosis is observed in 90 percent of cases of endobronchial TB; early diagnosis and prompt treatment prior to development of fibrosis are important to reduce the likelihood of this complication. Endobronchial disease in patients with primary infection has also been associated with impingement of enlarged lymph nodes on the bronchi [<a href="#rid63">63-66</a>]. Associated inflammation can lead to endobronchial ulceration or perforation. Other complications of endobronchial TB include obstruction, atelectasis (with or without secondary infection), bronchiectasis, and tracheal stenosis [<a href="#rid67">67</a>].</p><p class="headingAnchor" id="H12"><span class="h4">Symptoms</span><span class="headingEndMark"> — </span>Symptoms include a productive cough, chest pain, hemoptysis, lethargy, fever, and dyspnea. Symptoms may be acute in onset and be confused with bacterial pneumonia, asthma [<a href="#rid68">68</a>], or foreign body aspiration [<a href="#rid69">69</a>]. The clinical manifestations can also be subacute or chronic, resembling bronchogenic carcinoma [<a href="#rid69">69</a>].</p><p>A barking cough has been described in approximately two-thirds of patients with endobronchial disease, often accompanied by sputum production [<a href="#rid65">65-67,70,71</a>]. Rarely, patients develop so-called bronchorrhea, which is production of more than 500 mL/day of sputum [<a href="#rid72">72</a>]. In some cases, caseous material from endobronchial lesions or calcific material from extension of calcific nodes into the bronchi is expectorated (known as lithoptysis). Wheezing and hemoptysis may also be observed. Lymph node rupture can be associated with chest pain. The presence of dyspnea may signal obstruction or atelectasis.</p><p class="headingAnchor" id="H13"><span class="h4">Physical findings</span><span class="headingEndMark"> — </span>Physical findings can include diminished breath sounds, rhonchi, or wheezing. The wheeze typically is low pitched, monophonic, constant, and is auscultated consistently over the same area on the chest wall.</p><p class="headingAnchor" id="H14"><span class="h4">Radiologic findings</span><span class="headingEndMark"> — </span>The most common radiographic finding of endobronchial spread of TB in adults is upper lobe consolidation and cavity with ipsilateral spread to the lower lobe and, less commonly, contralateral lung. This may result in multiple small nodules with or without areas of consolidation and cavitation. Endobronchial spread can exist without extensive parenchymal abnormalities. </p><p>On high-resolution CT, endobronchial spread of pulmonary TB, typically manifested by centrilobular nodules, has been reported as high as 95 and 97 percent in various studies  (<a class="graphic graphic_diagnosticimage graphicRef134479" href="/d/graphic/134479.html" rel="external">image 4</a>) [<a href="#rid50">50,73</a>]. These centrilobular nodules are frequently connected to branching linear structures originating from a single "stalk" (the "tree-in-bud" appearance)  (<a class="graphic graphic_diagnosticimage graphicRef134480" href="/d/graphic/134480.html" rel="external">image 5</a>).</p><p>Manifestations of extensive bronchial involvement on high-resolution CT include segmental bronchial narrowing with concentric wall thickening, complete endobronchial obstruction, extrinsic obstruction by adjacent lymphadenopathy with scarring, and, rarely, fistulas [<a href="#rid5">5,74</a>]. Extensive endobronchial TB can also be associated with bronchiectasis. </p><p>In patients with primary disease and endobronchial TB, segmental atelectasis may be the only finding; atelectasis is more frequent in the right middle lobe and the anterior segment of the right upper lobe.</p><p class="headingAnchor" id="H15"><span class="h4">Evaluation and approach</span><span class="headingEndMark"> — </span>The diagnosis of endobronchial TB may be suspected based on the history and physical findings and chest radiography. Even with a highly suggestive high-resolution CT, the diagnosis should be confirmed by bronchoscopy with histopathology and microbiologic sampling. </p><p>Findings on bronchoscopy may include edematous-hyperemic lesions (with or without ulceration or fibrosis) or nonspecific bronchitis [<a href="#rid61">61</a>]. Hilar node rupture may be visible as a mass protruding into the bronchial lumen; with perforation of the node into the bronchus, caseous or calcific material may be seen extruding into the lumen. Bronchial stenosis also may be visible [<a href="#rid67">67,75</a>]. The tendency to develop bronchial stenosis can be predicted from bronchoscopic appearances of the mucosa. Edematous-hyperemic, fibrostenotic, and tumorous lesions tend to progress to eventual bronchial stenosis and/or obstruction within three months even with appropriate antituberculous therapy.</p><p>Brushings of the lesions or lavage of the distal airways can increase the frequency of positive smears; the yield for cultures of this material is &gt;90 percent [<a href="#rid53">53,59</a>]. (See  <a class="medical medical_review" href="/d/html/111683.html" rel="external">"Diagnosis of pulmonary tuberculosis in adults"</a>.)</p><p class="headingAnchor" id="H2126265625"><span class="h4">Complications</span><span class="headingEndMark"> — </span>Bronchial stenosis and stricture formation may develop in more than two-thirds of patients, despite appropriate antituberculous therapy. Severe airway obstruction may develop if the larger airways are involved. Postobstructive bronchiectasis is another complication that leads to frequent pneumonia and hemoptysis. Some patients also developed persistent obstructive airway disease.</p><p>Management of pulmonary TB with complications is discussed separately. (See  <a class="medical medical_review" href="/d/html/8015.html" rel="external">"Treatment of drug-susceptible pulmonary tuberculosis in nonpregnant adults without HIV infection", section on 'Pulmonary TB with complications'</a>.)</p><p class="headingAnchor" id="H17"><span class="h3">Lower lung tuberculosis</span><span class="headingEndMark"> — </span>In reactivation TB, the upper lobes are the most common site of disease. Sometimes only the lower lobes are affected; this can lead to misdiagnosis as viral or bacterial pneumonia, bronchiectasis, or carcinoma. </p><p>Lower lung TB refers to disease involvement below the hila (including the perihilar regions) on chest imaging [<a href="#rid76">76</a>]. The incidence in adults is 2 to 9 percent [<a href="#rid27">27,76</a>]. Consolidation in lower lung TB tends to be more extensive and homogeneous than upper lobe TB [<a href="#rid77">77-79</a>]. Cavitation may occur, and large cavities have been described. Symptoms in lower lobe TB are generally either subacute in onset (mean of 12 weeks) or chronic (up to 6 months). </p><p>Lower lobe involvement can be a manifestation of primary TB (with involvement of adjacent lymph nodes), reactivation TB (involving the superior segments of the lower lobes), or endobronchial TB [<a href="#rid77">77,78,80</a>]. Endobronchial TB can affect the lower lung in both primary infection (especially when adjacent lymph nodes are involved) and reactivation disease (spread from upper lobe disease can secondarily infect the lower lobes)  (<a class="graphic graphic_diagnosticimage graphicRef134479" href="/d/graphic/134479.html" rel="external">image 4</a>).</p><p>Older adult patients and those with HIV, diabetes, renal or hepatic disease, those receiving corticosteroids, and those with underlying silicosis appear at highest risk for lower lobe TB. However, many patients have no underlying medical illnesses. Studies in nursing homes suggest that lower lobe TB may be a manifestation of TB disease in an older, tuberculin-negative population with significant underlying diseases or anergy [<a href="#rid80">80</a>]. In some cases, the patients are suspected or known to have had previous TB but develop exogenous reinfection, perhaps due to a loss of demonstrable tissue hypersensitivity.</p><p class="headingAnchor" id="H18"><span class="h3">Tuberculoma</span><span class="headingEndMark"> — </span>A pulmonary tuberculoma is a well-circumscribed nodule or a mass. It consists of caseous material encapsulated by multiple concentric layers of connective tissue without surrounding inflammation or spread. Pulmonary tuberculomas can occur in both primary and reactivation TB and have been described in 6 to 9 percent of reactivation TB [<a href="#rid21">21</a>]. The proposed mechanism underlying the development of tuberculomas consists of repeated extension of bronchopneumonic foci, subsequent necrosis, and re-encapsulation. Other proposed mechanisms include shrinkage of occluded cavities and fusion of small encapsulated densities [<a href="#rid81">81</a>].</p><p>They are usually found in the upper lobes. A tuberculoma is one of the most common benign nodules and represents 5 to 24 percent of resected solitary pulmonary nodules [<a href="#rid82">82</a>]. They are usually a single nodule; multiple nodules can occur. The size ranges from &lt;1 cm to &gt;10 cm in diameter. The margins are usually smooth and sharp but may be irregular  (<a class="graphic graphic_diagnosticimage graphicRef134481" href="/d/graphic/134481.html" rel="external">image 6</a>); uncommonly, cavitation or calcification may be observed.</p><p>The natural history of tuberculomas without antituberculous therapy has been classified into progressive, stationary, and regressive; a stationary course accounts for 30 to 50 percent of all patients. In one series including 45 patients, symptoms were present in nearly half of cases; the most frequent symptoms were sputum, cough, general weakness, and fatigue [<a href="#rid83">83</a>]. </p><p>The diagnosis of tuberculoma can be difficult since airway cultures are often negative [<a href="#rid79">79</a>]. Fine needle aspiration or lung biopsy may be necessary for diagnosis. Tuberculomas may be accompanied by malignancy in rare cases. (See  <a class="medical medical_review" href="/d/html/6986.html" rel="external">"Diagnostic evaluation of the incidental pulmonary nodule"</a>.)</p><p>The majority of pulmonary tuberculomas are reduced in size by antituberculous treatment and this tendency may continue after completing treatment. In the early phase of treatment, a tuberculoma may increase in size and may require careful observation or re-evaluation with further biopsies or resection [<a href="#rid83">83</a>]. </p><p class="headingAnchor" id="H1237674724"><span class="h3">Laryngeal tuberculosis</span><span class="headingEndMark"> — </span>Laryngeal TB is divided into two forms based upon its pathogenesis: primary disease, which develops via direct invasion of bacilli into the larynx, and secondary disease, which develops via bronchogenic spread from advanced pulmonary TB or via hematogenous or lymphatic spread [<a href="#rid84">84</a>]. The most common sites of involvement include the true vocal cords, epiglottis, and false vocal cords. On laryngoscopy, areas of hyperemia, nodules, ulcerations, or exophytic masses can be seen. </p><p>Middle-aged males are four times more likely to be affected than females [<a href="#rid85">85</a>]. In one series including 127 US cases between 1970 and 2012, the mean duration of symptoms was 19 weeks (range 1 to 104 weeks) and mean age was 40.5 years [<a href="#rid86">86</a>]. The most common symptoms were dysphonia (96 percent), weight loss (46 percent), cough (38 percent), dysphagia (26 percent), odynophagia (25 percent), and stridor (9 percent). Radiographic evidence of pulmonary TB was reported in 86 percent of cases; however, laryngeal TB can occur in the absence of pulmonary disease. </p><p>In another series including 36 Brazilian patients with laryngeal TB, the main presenting symptoms were dysphagia and cough; the true vocal folds the most frequently affected site [<a href="#rid87">87</a>]. Smoking was associated with the development of more extensive lesions. </p><p>Laryngeal TB may be complicated by vocal cord paralysis. This can occur as a result of enlarged mediastinal lymph nodes compressing the recurrent laryngeal nerve along the intrathoracic course/aortopulmonary window or via stretching or entrapment of the recurrent laryngeal nerve due to mediastinal or lung fibrosis [<a href="#rid88">88</a>]. Stenosis is the most common complication despite adequate treatment. </p><p>CT and magnetic resonance imaging better demonstrate the involvement of the surrounding structures and tissues of the larynx than laryngoscopy. Biopsy of the primary growth is diagnostic and may show caseating granulomatous inflammation. Microbiologic confirmation is generally low yield.</p><p>Prior to the availability of antituberculous therapy, laryngeal TB was considered a terminal condition, as it usually occurred during progression of pulmonary disease, developing soon before death. Since the availability of antituberculous therapy, laryngeal TB has become relatively rare (&lt;1 percent of United States TB cases). Surgery is reserved for cases of airway compromise.</p><p class="headingAnchor" id="H2586484724"><span class="h2">Patients with HIV infection</span></p><p class="headingAnchor" id="H239520832"><span class="h3">Clinical manifestations</span></p><p class="headingAnchor" id="H3796312715"><span class="h4">General principles</span><span class="headingEndMark"> — </span>The clinical manifestations of TB in patients with HIV infection are influenced by the degree of immunosuppression [<a href="#rid89">89,90</a>]. Early in the course of HIV disease, the clinical presentation of TB is similar to that of HIV-uninfected patients; symptoms include fever, cough, weight loss, fatigue, loss of appetite, night sweats, and hemoptysis. Patients with HIV and diabetes are 31 times more likely to have TB disease if hemoptysis was a presenting symptom [<a href="#rid91">91</a>].</p><p>As immunity declines, the frequency of pulmonary cavitation and hemoptysis also declines [<a href="#rid89">89,90</a>]. HIV-infected patients with advanced immunosuppression are at increased risk of extrapulmonary TB and disseminated TB [<a href="#rid92">92-97</a>]. Virtually any site can be involved; the most common presentations are lymphadenitis and pleural involvement [<a href="#rid90">90,92,97-101</a>]. Septicemic-like illness with hypotension can occur, with high mortality rate unless diagnosed and treated rapidly. In contrast, TB disease may be subclinical in some patients with advanced immunosuppression, with no symptoms and a normal chest radiograph [<a href="#rid102">102</a>]. (See  <a class="medical medical_review" href="/d/html/8001.html" rel="external">"Tuberculous lymphadenitis"</a> and  <a class="medical medical_review" href="/d/html/8012.html" rel="external">"Tuberculous pleural effusion"</a>.)</p><p class="headingAnchor" id="H1712615081"><span class="h4">Effect of antiretroviral therapy</span><span class="headingEndMark"> — </span>In patients who develop TB disease while on antiretroviral therapy (ART), the clinical presentation depends on the level of immunosuppression. In one study from South Africa, the World Health Organization symptom screen (presence of any: active cough of any duration, fever, night sweats, or weight loss) had lower sensitivity among patients on ART than among patients not on ART (24 vs 47 percent), but higher specificity (94 vs 80 percent) [<a href="#rid103">103</a>].</p><p>Immune reconstitution inflammatory syndrome (IRIS) is an inflammatory disorder that can occur in association with initiation of ART in some HIV-infected individuals; it is typically associated with paradoxical worsening of pre-existing infectious processes, including TB. Issues related to IRIS are discussed separately. (See  <a class="medical medical_review" href="/d/html/3762.html" rel="external">"Immune reconstitution inflammatory syndrome", section on 'Tuberculosis'</a>.)</p><p class="headingAnchor" id="H664289430"><span class="h3">Radiologic findings</span><span class="headingEndMark"> — </span>Early in the course of HIV disease, radiologic findings of TB are similar to that of HIV-uninfected patients, as described in the preceding sections. (See <a class="local">'Radiologic findings'</a> above and <a class="local">'Radiologic findings'</a> above.)</p><p>As immunity declines (eg, in patients not treated with ART), radiologic findings are more likely to be atypical, including noncavitary pulmonary consolidation with no particular preference for the upper lobes  (<a class="graphic graphic_diagnosticimage graphicRef79587" href="/d/graphic/79587.html" rel="external">image 7</a> and <a class="graphic graphic_diagnosticimage graphicRef116255" href="/d/graphic/116255.html" rel="external">image 8</a>) [<a href="#rid89">89,90,104</a>]. HIV-infected patients with CD4 count &lt;200 cells/mm<sup>3</sup> are more likely to have mediastinal or hilar lymphadenopathy and extrapulmonary involvement and are less likely to have cavitation (compared with HIV-infected patients with CD4 count ≥200 cells/mm<sup>3</sup>). Miliary or disseminated disease has also been associated with severe immunosuppression [<a href="#rid24">24</a>].</p><p>In one study including 133 patients with HIV/acquired immunodeficiency syndrome (AIDS) and TB in New York City prior to the availability of ART, chest radiograph findings were as follows [<a href="#rid89">89</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Pattern typical for primary TB: 36 percent. These findings included pleural effusion, intrathoracic lymphadenopathy (mediastinum and hilum), or middle or lower lobe consolidation without cavitation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pattern compatible with reactivation TB: 29 percent. These findings included apical/posterior consolidation of the upper lobes or consolidation of the superior segments of the lower lobes (without adenopathy or effusion), endobronchial spread (acinar or 3 to 4 mm shadows, remote from a cavity or upper lobe consolidation), or bronchiectasis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Miliary pattern: 4 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Atypical findings for TB, such as diffuse infiltrates: 13 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Minimal changes: 5 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Normal chest radiographs: 14 percent.</p><p></p><p>Most patients with CD4 count ≥200 cells/mm<sup>3</sup> had typical patterns of reactivation disease (ie, cavitation and upper lobe consolidation), while patients with CD4 count &lt;200 cells/mm<sup>3</sup> were nearly as likely to have normal chest radiographs as they were to have patterns of reactivation disease (21 versus 23 percent). A number of other studies have also reported that normal chest radiographs are common in patients with CD4 counts &lt;200 cells/mm<sup>3</sup> [<a href="#rid92">92,105-108</a>].</p><p>Similarly, in a study from South India including 200 HIV-infected patients with CD4 &lt;200 cells/mm<sup>3</sup>, noncavitary infiltration and consolidation was the predominant finding [<a href="#rid109">109</a>]. Radiographic findings consisted of diffuse or mid and lower lung zone involvement, rather than classic upper lobe involvement. With restoration of cellular immunity on ART, radiographic findings are more likely to resemble those in patients with CD4 counts &gt;200 cells/mm<sup>3</sup>.</p><p>Chest CT is useful in patients with suspected pulmonary TB and normal or nonspecific abnormalities on the chest radiograph [<a href="#rid51">51</a>]. Even if there is no parenchymal disease, lymphadenopathy or pleural effusions may be observed.</p><p class="headingAnchor" id="H19"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Pulmonary complications of TB include hemoptysis, pneumothorax, bronchiectasis, extensive pulmonary destruction (including pulmonary gangrene), fistula, tracheobronchial stenosis, malignancy, and chronic pulmonary aspergillosis. These complications occur more commonly in the setting of reactivation disease. </p><p>Tuberculous effusions and empyema are discussed separately (See  <a class="medical medical_review" href="/d/html/8012.html" rel="external">"Tuberculous pleural effusion"</a>.)</p><p class="headingAnchor" id="H20"><span class="h2">Hemoptysis</span><span class="headingEndMark"> — </span>Hemoptysis occurs most frequently in the setting of TB disease but may also occur after completion of treatment [<a href="#rid110">110-112</a>]. Approximately 8 percent of patients with pulmonary TB infection experience hemoptysis at some point [<a href="#rid113">113</a>]. Many patients with hemoptysis are acid-fast bacilli (AFB) smear positive and usually have cavitary disease. Bleeding usually is of small volume, appearing as blood-streaked sputum. Massive hemoptysis is a rare complication since the advent of antituberculous therapy. Prior to effective treatment, massive hemoptysis accounted for approximately 5 percent of deaths from TB. In a South African case series, up to 73 percent of massive hemoptysis was attributable to TB disease [<a href="#rid114">114</a>]. </p><p>Sources of massive hemoptysis due to TB include the pulmonary artery, bronchial arteries, intercostal arteries, and other vessels supplying the lung. Tuberculous vascular lesions include pulmonary or bronchial arteritis and thrombosis, bronchial artery dilatation, and Rasmussen aneurysm. "Rasmussen's aneurysm" is a relatively uncommon cause of hemoptysis; it refers to the formation of an aneurysm in the setting of cavitary infection that extends into the adventitia and media of bronchial arteries, resulting in inflammation and thinning of the vessel wall [<a href="#rid115">115,116</a>]. This aneurysm subsequently ruptures into the cavity, producing massive hemoptysis.</p><p>Hemoptysis after the completion of therapy for TB only occasionally represents TB recurrence. Other causes include residual bronchiectasis, an aspergilloma or other fungus ball invading or colonizing an old healed cavity, a ruptured broncholith that erodes through a bronchial artery, a carcinoma, or another infectious or inflammatory process.</p><p>Flexible fiberoptic bronchoscopy is the initial procedure of choice for localization of bleeding and to achieve hemostasis. If urgent fiberoptic bronchoscopy is not available, then thoracic CT angiography can be used as a diagnostic modality to guide therapeutic intervention.</p><p>Patients with significant hemoptysis should be evaluated promptly to define the source of bleeding and to facilitate immediate intervention. Apart from impending exsanguination (which requires immediate surgical care), bronchial artery embolization is the preferred management approach if feasible [<a href="#rid117">117,118</a>]. In one study including 140 patients with TB and massive hemoptysis (more than 300 mL of blood in 24 hours) who underwent bronchial artery embolization, nearly complete control of hemoptysis was achieved in 73 percent of cases [<a href="#rid117">117</a>]. In the absence of access to appropriate facilities for bronchial artery embolization, other treatments include bed rest, postural management, volume replacement, cough suppression, and intravenous <a class="drug drug_general" data-topicid="10039" href="/d/drug information/10039.html" rel="external">vasopressin</a> [<a href="#rid119">119</a>]. (See  <a class="medical medical_review" href="/d/html/4394.html" rel="external">"Evaluation and management of life-threatening hemoptysis"</a>.)</p><p>If embolization and medical management fail, surgical options include ligation of arteries, resection of a lung lobe, and endobronchial tamponade. Both ligation and embolization can be complex because of the frequent presence of multiple feeder arteries often connecting systemic with bronchial circulation [<a href="#rid120">120</a>]. Elective resection is associated with a mortality of 18 percent, and emergency lung resection for life-threatening hemoptysis a mortality up to 40 percent [<a href="#rid121">121</a>]. Older studies suggest that after an episode of massive hemoptysis or repeated episodes of severe hemoptysis, surgical intervention improves survival [<a href="#rid122">122-124</a>] and should be considered if embolization fails.</p><p class="headingAnchor" id="H22"><span class="h2">Pneumothorax</span><span class="headingEndMark"> — </span>Prior to the availability of antituberculous therapy, spontaneous pneumothorax was a frequent and dangerous complication of pulmonary TB [<a href="#rid125">125</a>]. Since the availability of antituberculous therapy, spontaneous pneumothorax associated with TB has been reported in about 1 percent of hospitalized patients [<a href="#rid126">126-128</a>]. A case series from Turkey reported pneumothorax in 1.5 percent of cases of pulmonary TB [<a href="#rid128">128</a>]. In regions where TB is endemic, it may be the most common cause of spontaneous pneumothorax [<a href="#rid129">129</a>].</p><p>Pneumothorax appears to result from the rupture of a peripheral cavity or a subpleural caseous focus with liquefaction into the pleural space [<a href="#rid126">126,127</a>]. Inflammation can lead to development of a bronchopleural fistula, which can persist or seal off spontaneously. The lung may reexpand if the bronchopleural fistula seals spontaneously, but more commonly chest tube drainage is required.</p><p>Factors preventing successful chest tube drainage and expansion include extensive pulmonary parenchymal disease with large fistulas, a long interval between pneumothorax and chest tube insertion, and the development of an empyema due to TB and/or bacterial superinfection. However, successful closure of even extensive air leaks has been reported after as much as six weeks of chest tube drainage accompanied by appropriate antituberculous therapy [<a href="#rid130">130</a>]. (See  <a class="medical medical_review" href="/d/html/6691.html" rel="external">"Treatment of secondary spontaneous pneumothorax in adults"</a>.)</p><p class="headingAnchor" id="H23"><span class="h2">Bronchiectasis</span><span class="headingEndMark"> — </span>Bronchiectasis may develop following primary or reactivation TB and can be associated with hemoptysis [<a href="#rid131">131-136</a>]. (See  <a class="medical medical_review" href="/d/html/1444.html" rel="external">"Clinical manifestations and diagnosis of bronchiectasis in adults"</a>.)</p><p>Following primary TB infection, extrinsic compression of a bronchus by enlarged nodes may cause bronchial dilation distal to the obstruction. There may be no evidence of parenchymal TB.</p><p>In the setting of reactivation TB, progressive destruction and fibrosis of lung parenchyma may lead to localized bronchial dilation. If endobronchial disease is present, bronchial stenosis may result in distal bronchiectasis. Bronchiectasis is more frequent in the common sites of reactivation TB (apical and posterior segments of the upper lobe) but may be found in other areas of the lung.</p><p class="headingAnchor" id="H2533216963"><span class="h2">Broncholithiasis</span><span class="headingEndMark"> — </span>Broncholithiasis is defined as the presence of calcified or ossified material within the lumen of the tracheobronchial tree; it is an uncommon complication of pulmonary TB. The calcific nidus in a tuberculous lymph node erodes into the bronchial wall and may occlude the bronchus [<a href="#rid54">54</a>]. Presenting symptoms may include cough, hemoptysis, wheezing, or evidence of recurrent pneumonia [<a href="#rid137">137</a>].</p><p class="headingAnchor" id="H24"><span class="h2">Extensive pulmonary destruction</span><span class="headingEndMark"> — </span>Rarely, untreated or inadequately treated TB can cause progressive, extensive destruction of areas of one or both lungs [<a href="#rid138">138,139</a>]. In primary TB, occasionally lymph node obstruction of the bronchi together with distal collapse, necrosis, and bacterial superinfection can produce parenchymal destruction [<a href="#rid139">139</a>]. More commonly, destruction results from chronic reactivation TB, typically in the absence of effective antituberculous therapy. Symptoms include progressive dyspnea, hemoptysis, and weight loss.</p><p>Pulmonary gangrene refers to acute pulmonary destruction which occurs as a rare complication of severe pulmonary infection. It has been described most frequently in the setting of pulmonary infection due to <em>Klebsiella pneumonia</em> or <em>Streptococcus pneumonia</em>; pulmonary gangrene due to TB has also been described [<a href="#rid140">140,141</a>]. Pulmonary gangrene occurs as a consequence of arteritis and thrombosis of distal pulmonary vessels, leading to an inflammatory pyogenic process and massive necrosis of lung parenchyma. </p><p>This form of TB progresses rapidly from a homogeneous, extensive infiltrate to dense consolidation. Air-filled cysts develop and coalesce into cavities. Necrotic lung tissue attached to the wall of the cavity may be observed. Pulmonary gangrene may resemble an intracavitary clot, fungus ball, or Rasmussen's aneurysm. The presence of a mobile mass that contains pulmonary tissue within a pulmonary cavity is characteristic on computed tomography scanning.</p><p>Resolution with effective antimicrobial therapy has been described [<a href="#rid141">141</a>]. In many cases, urgent surgical intervention is needed because of life-threatening complications such as acute respiratory failure and shock that persist despite appropriate antimicrobial therapy [<a href="#rid141">141</a>].</p><p>Mortality usually is high; in one series including four patients, three died [<a href="#rid140">140</a>]. In another series including 18 patients with extensive destruction of one or both lungs, eight died [<a href="#rid138">138</a>]. Causes of death were massive hemoptysis and respiratory failure, sometimes in the presence of TB disease or superinfection. Radiographically, patients had large cavities and fibrosis of remaining lung; in some cases, air-fluid levels at the base of the destroyed lung were observed [<a href="#rid138">138,139</a>].</p><p class="headingAnchor" id="H1177537470"><span class="h2">Respiratory failure</span><span class="headingEndMark"> — </span>Acute respiratory distress syndrome (ARDS) requiring mechanical ventilation as a presentation of TB is rarely reported. Mortality rates range between 47 and 80 percent. Patients with miliary or disseminated TB were significantly more likely to develop respiratory failure requiring mechanical ventilation despite the availability of effective antituberculous therapy [<a href="#rid142">142</a>]. </p><p class="headingAnchor" id="H3753409"><span class="h2">Septic shock</span><span class="headingEndMark"> — </span>TB can cause septic shock; the manifestations are similar to bacterial septic shock. Compared with patients with septic shock due to other pathogens, patients with septic shock due to TB have lower mean body mass indices (22 versus 27), lower mean white blood counts (10.4 versus 16.2), and are more often HIV infected (15 versus 3 percent) [<a href="#rid143">143</a>]. The probability of survival in patients with <em>M. tuberculosis</em> septic shock is extremely poor, with an in hospital mortality rate of 79 percent; delayed initiation of appropriate therapy likely played an important role in clinical outcome [<a href="#rid143">143</a>]. Extrapulmonary disease may be observed in more than 50 percent of cases. (See  <a class="medical medical_review" href="/d/html/1657.html" rel="external">"Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis"</a>.)</p><p class="headingAnchor" id="H13013757"><span class="h2">Malignancy</span><span class="headingEndMark"> — </span>A study conducted by the National Cancer Institute found that pulmonary TB was associated with an increased risk of lung cancer, after adjustment for active smoking and socioeconomic status (odds ratio 2.1, 95% CI 1.4-3.1) [<a href="#rid144">144</a>]. Similarly, in a meta-analysis from China, TB was associated with a 1.78-fold increase in the risk of lung cancer among nonsmokers and an association with adenocarcinoma (relative risk 1.6; 95% CI 1.2-2.1) [<a href="#rid145">145</a>]. </p><p>TB is thought to increase lung cancer risk via chronic pulmonary inflammation and fibrosis, but no causal relationship has been established. TB infection may cause a profound and extended host immune response, with inflammatory cells in the lung producing extensive cytokine signaling cascades, reactive nitrogen and oxygen species, prostaglandins, and tissue-destructive proteases. Mycobacterial cell wall components may induce production of nitric oxide and reactive oxygen species, which have been implicated in deoxyribonucleic acid (DNA) damage leading to carcinogenesis [<a href="#rid146">146</a>]. Chronic inflammation may also enhance mutagenesis. In addition, immunosuppression and radiation therapy administered for treatment of lung cancer may be associated with an increased risk of TB. </p><p class="headingAnchor" id="H31288462"><span class="h2">Venous thromboembolism</span><span class="headingEndMark"> — </span>TB, both pulmonary and extrapulmonary, has been suggested as an independent risk factor for venous thromboembolism (VTE), perhaps due to a hypercoagulable state. In a systematic review and meta-analysis including more than 16,000 patients with TB disease, the prevalence of VTE was 3.5 percent, the prevalence of pulmonary embolism was 5.8 percent and the prevalence of deep vein thrombosis was 1.3 percent. Patients with TB disease had a higher risk for VTE (odds ratio [OR] 2.90, 95% CI 2.30-3.67), DVT (OR 1.56, 95% CI 1.14-2.14), and PE (OR 3.58, 95% CI 2.54-5.05) [<a href="#rid147">147</a>]. </p><p>The clinical approach to VTE is discussed further separately. (See  <a class="medical medical_review" href="/d/html/8253.html" rel="external">"Epidemiology and pathogenesis of acute pulmonary embolism in adults"</a>.)</p><p class="headingAnchor" id="H1528583"><span class="h2">Chronic pulmonary aspergillosis</span><span class="headingEndMark"> — </span>Chronic pulmonary aspergillosis can be a sequela of pulmonary TB, especially in those with cavitary disease. This is discussed further separately. (See  <a class="medical medical_review" href="/d/html/2441.html" rel="external">"Chronic pulmonary aspergillosis: Epidemiology, clinical manifestations and diagnosis", section on 'Epidemiology and risk factors'</a>.)</p><p class="headingAnchor" id="H9468869"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The following conditions can cause cavitary pulmonary lesions and symptoms suggestive of TB including fever, cough, and weight loss:</p><p class="bulletIndent1"><span class="glyph">●</span>Nontuberculous mycobacterial infection (NTM) – Symptoms of NTM include fatigue, dyspnea, and occasional hemoptysis; fever and weight loss occur less frequently than in patients with TB. Clinical features of <em>Mycobacterium kansasii</em> are often very similar to those of TB. NTM is distinguished from TB by culture results and/or molecular diagnostic testing. (See  <a class="medical medical_review" href="/d/html/5342.html" rel="external">"Overview of nontuberculous mycobacterial infections"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fungal infection – Fungal pneumonia can present with a range of manifestations including pneumonia, pulmonary nodule, and cavitary lung disease. It is distinguished from TB by epidemiologic exposure and culture results. (See  <a class="medical medical_review" href="/d/html/2451.html" rel="external">"Diagnosis and treatment of pulmonary histoplasmosis"</a> and  <a class="medical medical_review" href="/d/html/15717.html" rel="external">"Diagnosis of invasive aspergillosis"</a> and  <a class="medical medical_review" href="/d/html/2465.html" rel="external">"Mucormycosis (zygomycosis)"</a> and  <a class="medical medical_review" href="/d/html/2437.html" rel="external">"Clinical manifestations and diagnosis of blastomycosis"</a> and  <a class="medical medical_review" href="/d/html/3757.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of Cryptococcus neoformans meningoencephalitis in patients with HIV"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sarcoidosis – Sarcoidosis most commonly presents with diffuse interstitial lung disease. It rarely forms cavities and is distinguished from TB by histopathologic detection of noncaseating granulomas. (See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Melioidosis – Melioidosis is an infection caused by the bacterium <em>Burkholderia pseudomallei</em>. It can present with chronic cough, purulent sputum production, hemoptysis, and night sweats. In addition, imaging findings can mimic TB with cavitating, nodular, or streaky infiltrates with fibrotic changes. Uncommonly, infection can be latent and subsequently activate, as with TB. (See  <a class="medical medical_review" href="/d/html/3146.html" rel="external">"Melioidosis: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lung abscess – Lung abscess generally presents with fever, cough, and sputum production but without shaking chills or true rigors. Chest imaging usually shows infiltrates with a cavity. The diagnosis is established based on culture results. (See  <a class="medical medical_review" href="/d/html/7030.html" rel="external">"Lung abscess in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Septic emboli – Septic emboli to the lung from an extrapulmonary nidus are distinguished from TB by blood culture results and echocardiography. (See  <a class="medical medical_review" href="/d/html/2142.html" rel="external">"Complications and outcome of infective endocarditis", section on 'Septic embolization'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lung cancer – Lung cancer most commonly presents with cough, hemoptysis, chest pain, and dyspnea. It is distinguished from TB by histopathology. (See  <a class="medical medical_review" href="/d/html/4641.html" rel="external">"Clinical manifestations of lung cancer"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lymphoma – Lymphoma typically presents with a rapidly growing mass together with fever, night sweats, and weight loss. It is distinguished from TB by histopathology. (See related topics.)</p><p></p><p class="headingAnchor" id="H665067269"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118986.html" rel="external">"Society guideline links: Hemoptysis"</a>.)</p><p class="headingAnchor" id="H25"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/15485.html" rel="external">"Patient education: Tuberculosis (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/d/html/4012.html" rel="external">"Patient education: Tuberculosis (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H1529399"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Natural history</strong> – Inhalation of aerosolized droplets containing<em> M. tuberculosis</em> leads to deposition in the lungs, with one of the following possible outcomes (see <a class="local">'Natural history'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Immediate clearance of the organism</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>TB infection (previously termed latent TB) – TB infection refers to containment of viable organisms via host immunity, in the absence of signs or symptoms of illness.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Reactivation TB disease – Reactivation TB disease refers to onset of symptomatic TB disease, years following a period of contained TB infection.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Primary TB disease – Primary TB refers to immediate onset of TB disease following <em>M. tuberculosis</em> exposure in a previously naïve host. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disease forms</strong> − Clinical manifestations of pulmonary tuberculosis (TB) include primary TB, reactivation and reactivation TB, endobronchial TB, lower lung field TB, tuberculoma, and laryngeal TB.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Primary TB</strong> − Among patients with primary TB, clinical manifestations have been observed in approximately one-third of cases. Symptoms include fever and chest pain. Retrosternal pain and dull interscapular pain have been ascribed to enlarged bronchial lymph nodes. The physical exam is generally normal. The most common chest radiograph abnormality in one large series was hilar lymphadenopathy. Other manifestations include pleural effusions and pulmonary infiltrates. (See <a class="local">'Primary tuberculosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Reactivation TB</strong> − Reactivation TB refers to reactivation of a previously dormant focus seeded at the time of the primary infection. The apical and posterior segments of the upper lobes are the sites most frequently involved. Typically, symptoms are insidious and may include cough, weight loss, fatigue, fever, night sweats, chest pain, dyspnea, and/or hemoptysis; these findings are observed less frequently among patients &gt;60 years. Exogenous reinfection in a previously infected person may present with similar findings. (See <a class="local">'Reactivation (postprimary) tuberculosis'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Endobronchial TB</strong> − Endobronchial TB may develop via direct extension to the bronchi from an adjacent parenchymal focus (usually a cavity) or via spread of organisms to the bronchi via infected sputum. It can occur in patients with primary TB or reactivation TB and was observed more frequently prior to the antituberculous therapy era. Symptoms may be acute or chronic; a barking cough has been described in approximately two-thirds of patients. (See <a class="local">'Endobronchial tuberculosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with HIV infection</strong> − The clinical manifestations of TB in patients with HIV infection are influenced by the degree of immunosuppression. As immunity declines, extrapulmonary TB and disseminated TB are more common. Immune reconstitution inflammatory syndrome can occur with initiation of antiretroviral therapy in some individuals living with HIV and is associated with paradoxic worsening of TB. (See <a class="local">'Patients with HIV infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary complications</strong> − Pulmonary complications of TB include hemoptysis, pneumothorax, bronchiectasis, extensive pulmonary destruction (including pulmonary gangrene), acute respiratory distress syndrome, septic shock, malignancy, venous thromboembolism, and chronic pulmonary aspergillosis. (See <a class="local">'Complications'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Behr MA, Kaufmann E, Duffin J, et al. Latent Tuberculosis: Two Centuries of Confusion. Am J Respir Crit Care Med 2021; 204:142.</a></li><li><a class="nounderline abstract_t">Verrall AJ, Netea MG, Alisjahbana B, et al. Early clearance of Mycobacterium tuberculosis: a new frontier in prevention. Immunology 2014; 141:506.</a></li><li><a class="nounderline abstract_t">Houk VN, Baker JH, Sorensen K, Kent DC. The epidemiology of tuberculosis infection in a closed environment. Arch Environ Health 1968; 16:26.</a></li><li><a class="nounderline abstract_t">de Martino M, Lodi L, Galli L, Chiappini E. Immune Response to Mycobacterium tuberculosis: A Narrative Review. Front Pediatr 2019; 7:350.</a></li><li><a class="nounderline abstract_t">Burrill J, Williams CJ, Bain G, et al. Tuberculosis: a radiologic review. Radiographics 2007; 27:1255.</a></li><li><a class="nounderline abstract_t">Donald PR, Diacon AH, Thee S. Anton Ghon and His Colleagues and Their Studies of the Primary Focus and Complex of Tuberculosis Infection and Their Relevance for the Twenty-First Century. Respiration 2021; 100:557.</a></li><li><a class="nounderline abstract_t">Skoura E, Zumla A, Bomanji J. Imaging in tuberculosis. Int J Infect Dis 2015; 32:87.</a></li><li><a class="nounderline abstract_t">Comstock GW. Epidemiology of tuberculosis. Am Rev Respir Dis 1982; 125:8.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Tuberculosis: Basic TB Facts. http://www.cdc.gov/tb/topic/basics/risk.htm (Accessed on March 10, 2015).</li><li><a class="nounderline abstract_t">Sloot R, Schim van der Loeff MF, Kouw PM, Borgdorff MW. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. Am J Respir Crit Care Med 2014; 190:1044.</a></li><li><a class="nounderline abstract_t">National action plan to combat multidrug-resistant tuberculosis. MMWR Recomm Rep 1992; 41:5.</a></li><li><a class="nounderline abstract_t">Horsburgh CR Jr, Rubin EJ. Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med 2011; 364:1441.</a></li><li><a class="nounderline abstract_t">Bates MN, Khalakdina A, Pai M, et al. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007; 167:335.</a></li><li><a class="nounderline abstract_t">Smith GS, Van Den Eeden SK, Baxter R, et al. Cigarette smoking and pulmonary tuberculosis in northern California. J Epidemiol Community Health 2015; 69:568.</a></li><li><a class="nounderline abstract_t">Heimbeck J. The infection of tuberculosis. Acta Med Scand 1930; 74:143.</a></li><li><a class="nounderline abstract_t">Andrews JR, Noubary F, Walensky RP, et al. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis 2012; 54:784.</a></li><li><a class="nounderline abstract_t">Stead WW, Kerby GR, Schlueter DP, Jordahl CW. The clinical spectrum of primary tuberculosis in adults. Confusion with reinfection in the pathogenesis of chronic tuberculosis. Ann Intern Med 1968; 68:731.</a></li><li><a class="nounderline abstract_t">Buckner CB, Walker CW. Radiologic manifestations of adult tuberculosis. J Thorac Imaging 1990; 5:28.</a></li><li><a class="nounderline abstract_t">POULSEN A. Some clinical features of tuberculosis. Acta Tuberc Scand 1957; 33:37.</a></li><li><a class="nounderline abstract_t">Choyke PL, Sostman HD, Curtis AM, et al. Adult-onset pulmonary tuberculosis. Radiology 1983; 148:357.</a></li><li><a class="nounderline abstract_t">Krysl J, Korzeniewska-Kosela M, Müller NL, FitzGerald JM. Radiologic features of pulmonary tuberculosis: an assessment of 188 cases. Can Assoc Radiol J 1994; 45:101.</a></li><li><a class="nounderline abstract_t">Khan MA, Kovnat DM, Bachus B, et al. Clinical and roentgenographic spectrum of pulmonary tuberculosis in the adult. Am J Med 1977; 62:31.</a></li><li><a class="nounderline abstract_t">Woodring JH, Vandiviere HM, Fried AM, et al. Update: the radiographic features of pulmonary tuberculosis. AJR Am J Roentgenol 1986; 146:497.</a></li><li><a class="nounderline abstract_t">Jeong YJ, Lee KS. Pulmonary tuberculosis: up-to-date imaging and management. AJR Am J Roentgenol 2008; 191:834.</a></li><li><a class="nounderline abstract_t">Lee KS, Song KS, Lim TH, et al. Adult-onset pulmonary tuberculosis: findings on chest radiographs and CT scans. AJR Am J Roentgenol 1993; 160:753.</a></li><li><a class="nounderline abstract_t">Heo JN, Choi YW, Jeon SC, Park CK. Pulmonary tuberculosis: another disease showing clusters of small nodules. AJR Am J Roentgenol 2005; 184:639.</a></li><li><a class="nounderline abstract_t">Barnes PF, Verdegem TD, Vachon LA, et al. Chest roentgenogram in pulmonary tuberculosis. New data on an old test. Chest 1988; 94:316.</a></li><li><a class="nounderline abstract_t">Arango L, Brewin AW, Murray JF. The spectrum of tuberculosis as currently seen in a metropolitan hospital. Am Rev Respir Dis 1973; 108:805.</a></li><li><a class="nounderline abstract_t">MacGregor RR. A year's experience with tuberculosis in a private urban teaching hospital in the postsanatorium era. Am J Med 1975; 58:221.</a></li><li><a class="nounderline abstract_t">Mayock RL, MacGregor RR. Diagnosis, prevention and early therapy of tuberculosis. Dis Mon 1976; 22:1.</a></li><li><a class="nounderline abstract_t">Verver S, Bwire R, Borgdorff MW. Screening for pulmonary tuberculosis among immigrants: estimated effect on severity of disease and duration of infectiousness. Int J Tuberc Lung Dis 2001; 5:419.</a></li><li><a class="nounderline abstract_t">Miller LG, Asch SM, Yu EI, et al. A population-based survey of tuberculosis symptoms: how atypical are atypical presentations? Clin Infect Dis 2000; 30:293.</a></li><li><a class="nounderline abstract_t">Miller AC, Arakkal AT, Koeneman S, et al. Incidence, duration and risk factors associated with delayed and missed diagnostic opportunities related to tuberculosis: a population-based longitudinal study. BMJ Open 2021; 11:e045605.</a></li><li><a class="nounderline abstract_t">Hongguang C, Min L, Shiwen J, et al. Impact of diabetes on clinical presentation and treatment outcome of pulmonary tuberculosis in Beijing. Epidemiol Infect 2015; 143:150.</a></li><li><a class="nounderline abstract_t">Alemu A, Bitew ZW, Seid G, et al. Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports. PLoS One 2022; 17:e0277807.</a></li><li><a class="nounderline abstract_t">Oursler KK, Moore RD, Bishai WR, et al. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis 2002; 34:752.</a></li><li><a class="nounderline abstract_t">Wood R, Middelkoop K, Myer L, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 2007; 175:87.</a></li><li><a class="nounderline abstract_t">Pérez-Guzmán C, Vargas MH, Torres-Cruz A, Villarreal-Velarde H. Does aging modify pulmonary tuberculosis?: A meta-analytical review. Chest 1999; 116:961.</a></li><li><a class="nounderline abstract_t">Mathur P, Sacks L, Auten G, et al. Delayed diagnosis of pulmonary tuberculosis in city hospitals. Arch Intern Med 1994; 154:306.</a></li><li><a class="nounderline abstract_t">Bobrowitz ID. Active tuberculosis undiagnosed until autopsy. Am J Med 1982; 72:650.</a></li><li><a class="nounderline abstract_t">Breen RA, Leonard O, Perrin FM, et al. How good are systemic symptoms and blood inflammatory markers at detecting individuals with tuberculosis? Int J Tuberc Lung Dis 2008; 12:44.</a></li><li><a class="nounderline abstract_t">Lee P, Ho KK. Hyponatremia in pulmonary TB: evidence of ectopic antidiuretic hormone production. Chest 2010; 137:207.</a></li><li><a class="nounderline abstract_t">Day JH, Charalambous S, Fielding KL, et al. Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa. Int J Tuberc Lung Dis 2006; 10:523.</a></li><li><a class="nounderline abstract_t">POPPIUS H, THOMANDER K. Segmentary distribution of cavities; a radiologic study of 500 consecutive cases of cavernous pulmonary tuberculosis. Ann Med Intern Fenn 1957; 46:113.</a></li><li><a class="nounderline abstract_t">Farman DP, Speir WA Jr. Initial roentgenographic manifestations of bacteriologically proven Mycobacterium tuberculosis. Typical or atypical? Chest 1986; 89:75.</a></li><li><a class="nounderline abstract_t">LENTINO W, JACOBSON HG, POPPEL MH. Segmental localization of upper lobe tuberculosis; the rarity of anterior involvement. Am J Roentgenol Radium Ther Nucl Med 1957; 77:1042.</a></li><li><a class="nounderline abstract_t">Nachiappan AC, Rahbar K, Shi X, et al. Pulmonary Tuberculosis: Role of Radiology in Diagnosis and Management. Radiographics 2017; 37:52.</a></li><li><a class="nounderline abstract_t">Miller WT, MacGregor RR. Tuberculosis: frequency of unusual radiographic findings. AJR Am J Roentgenol 1978; 130:867.</a></li><li><a class="nounderline abstract_t">Marciniuk DD, McNab BD, Martin WT, Hoeppner VH. Detection of pulmonary tuberculosis in patients with a normal chest radiograph. Chest 1999; 115:445.</a></li><li><a class="nounderline abstract_t">Im JG, Itoh H, Shim YS, et al. Pulmonary tuberculosis: CT findings--early active disease and sequential change with antituberculous therapy. Radiology 1993; 186:653.</a></li><li><a class="nounderline abstract_t">Expert Panel on Thoracic Imaging:, Ravenel JG, Chung JH, et al. ACR Appropriateness Criteria® Imaging of Possible Tuberculosis. J Am Coll Radiol 2017; 14:S160.</a></li><li><a class="nounderline abstract_t">Im JG, Itoh H, Han MC. CT of pulmonary tuberculosis. Semin Ultrasound CT MR 1995; 16:420.</a></li><li><a class="nounderline abstract_t">Hoheisel G, Chan BK, Chan CH, et al. Endobronchial tuberculosis: diagnostic features and therapeutic outcome. Respir Med 1994; 88:593.</a></li><li><a class="nounderline abstract_t">Salkin D, Cadden AV, Edson RC. The natural history of tuberculous tracheobronchitis. Am Rev Tuberc 1943; 47:351.</a></li><li><a class="nounderline abstract_t">Wilson NJ. Bronchoscopic observations in tuberculosis tracheobronchitis: Clinical and pathological correlations. Dis Chest 1945; 11:36.</a></li><li><a class="nounderline abstract_t">MacRAE DM, HILTZ JE, QUINLAN JJ. Bronchoscopy in a sanatorium; a review of 522 consecutive bronchoscopies. Am Rev Tuberc 1950; 61:355.</a></li><li><a class="nounderline abstract_t">AUERBACH O. Tuberculosis of the trachea and major bronchi. Am Rev Tuberc 1949; 60:604.</a></li><li><a class="nounderline abstract_t">Siow WT, Lee P. Tracheobronchial tuberculosis: a clinical review. J Thorac Dis 2017; 9:E71.</a></li><li><a class="nounderline abstract_t">Shim YS. Endobronchial tuberculosis. Respirology 1996; 1:95.</a></li><li><a class="nounderline abstract_t">Kashyap S, Mohapatra PR, Saini V. Endobronchial tuberculosis. Indian J Chest Dis Allied Sci 2003; 45:247.</a></li><li><a class="nounderline abstract_t">Chung HS, Lee JH. Bronchoscopic assessment of the evolution of endobronchial tuberculosis. Chest 2000; 117:385.</a></li><li><a class="nounderline abstract_t">Jung SS, Park HS, Kim JO, Kim SY. Incidence and clinical predictors of endobronchial tuberculosis in patients with pulmonary tuberculosis. Respirology 2015; 20:488.</a></li><li><a class="nounderline abstract_t">LINCOLN EM, HARRIS LC, BOVORNKITTI S, CARRETERO R. The course and prognosis of endobronchial tuberculosis in children. Am Rev Tuberc 1956; 74:246.</a></li><li><a class="nounderline abstract_t">Frostad S. Lymph node perforation through the bronchial tree in children with primary tuberculosis. Acta Tuberc Scand 1959; 47:104.</a></li><li><a class="nounderline abstract_t">Lee JH, Park SS, Lee DH, et al. Endobronchial tuberculosis. Clinical and bronchoscopic features in 121 cases. Chest 1992; 102:990.</a></li><li><a class="nounderline abstract_t">Ip MS, So SY, Lam WK, Mok CK. Endobronchial tuberculosis revisited. Chest 1986; 89:727.</a></li><li><a class="nounderline abstract_t">Seiden HS, Thomas P. Endobronchial tuberculosis and its sequelae. Can Med Assoc J 1981; 124:165.</a></li><li><a class="nounderline abstract_t">Caglayan S, Coteli I, Acar U, Erkin S. Endobronchial tuberculosis simulating foreign body aspiration. Chest 1989; 95:1164.</a></li><li><a class="nounderline abstract_t">Matthews JI, Matarese SL, Carpenter JL. Endobronchial tuberculosis simulating lung cancer. Chest 1984; 86:642.</a></li><li><a class="nounderline abstract_t">Van den Brande PM, Van de Mierop F, Verbeken EK, Demedts M. Clinical spectrum of endobronchial tuberculosis in elderly patients. Arch Intern Med 1990; 150:2105.</a></li><li><a class="nounderline abstract_t">So SY, Lam WK, Sham MK. Bronchorrhea. A presenting feature of active endobronchial tuberculosis. Chest 1983; 84:635.</a></li><li><a class="nounderline abstract_t">Williams DJ, York EL, Nobert EJ, Sproule BJ. Endobronchial tuberculosis presenting as asthma. Chest 1988; 93:836.</a></li><li><a class="nounderline abstract_t">Hatipoğlu ON, Osma E, Manisali M, et al. High resolution computed tomographic findings in pulmonary tuberculosis. Thorax 1996; 51:397.</a></li><li><a class="nounderline abstract_t">Shahzad T, Irfan M. Endobronchial tuberculosis-a review. J Thorac Dis 2016; 8:3797.</a></li><li><a class="nounderline abstract_t">Albert RK, Petty TL. Endobronchial tuberculosis progressing to bronchial stenosis. Fiberoptic bronchoscopic manifestations. Chest 1976; 70:537.</a></li><li><a class="nounderline abstract_t">SEGARRA F, SHERMAN DS, RODRIGUEZ-AGUERO J. Lower lung field tuberculosis. Am Rev Respir Dis 1963; 87:37.</a></li><li><a class="nounderline abstract_t">Chang SC, Lee PY, Perng RP. Lower lung field tuberculosis. Chest 1987; 91:230.</a></li><li><a class="nounderline abstract_t">Parmar MS. Lower lung field tuberculosis. Am Rev Respir Dis 1967; 96:310.</a></li><li><a class="nounderline abstract_t">STEELE JD. THE SOLITARY PULMONARY NODULE. REPORT OF A COOPERATIVE STUDY OF RESECTED ASYMPTOMATIC SOLITARY PULMONARY NODULES IN MALES. J Thorac Cardiovasc Surg 1963; 46:21.</a></li><li><a class="nounderline abstract_t">Stead WW. Tuberculosis among elderly persons: an outbreak in a nursing home. Ann Intern Med 1981; 94:606.</a></li><li><a class="nounderline abstract_t">Pratt PC. Pathology of tuberculosis. Semin Roentgenol 1979; 14:196.</a></li><li><a class="nounderline abstract_t">Zwirewich CV, Vedal S, Miller RR, Müller NL. Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology 1991; 179:469.</a></li><li><a class="nounderline abstract_t">Lee HS, Oh JY, Lee JH, et al. Response of pulmonary tuberculomas to anti-tuberculous treatment. Eur Respir J 2004; 23:452.</a></li><li><a class="nounderline abstract_t">Kulkarni NS, Gopal GS, Ghaisas SG, Gupte NA. Epidemiological considerations and clinical features of ENT tuberculosis. J Laryngol Otol 2001; 115:555.</a></li><li><a class="nounderline abstract_t">Agarwal R, Gupta L, Singh M, et al. Primary Laryngeal Tuberculosis: A Series of 15 Cases. Head Neck Pathol 2019; 13:339.</a></li><li><a class="nounderline abstract_t">Benwill JL, Sarria JC. Laryngeal tuberculosis in the United States of America: a forgotten disease. Scand J Infect Dis 2014; 46:241.</a></li><li><a class="nounderline abstract_t">Reis JG, Reis CS, da Costa DC, et al. Factors Associated with Clinical and Topographical Features of Laryngeal Tuberculosis. PLoS One 2016; 11:e0153450.</a></li><li><a class="nounderline abstract_t">Rajasekaran V, Srividhya G. A clinical study on laryngeal manifestations of tuberculosis. Int J Otolaryngol 2017; 3:845.</a></li><li><a class="nounderline abstract_t">Greenberg SD, Frager D, Suster B, et al. Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance). Radiology 1994; 193:115.</a></li><li><a class="nounderline abstract_t">Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324:1644.</a></li><li><a class="nounderline abstract_t">Berkowitz N, Okorie A, Goliath R, et al. The prevalence and determinants of active tuberculosis among diabetes patients in Cape Town, South Africa, a high HIV/TB burden setting. Diabetes Res Clin Pract 2018; 138:16.</a></li><li><a class="nounderline abstract_t">Jones BE, Young SM, Antoniskis D, et al. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148:1292.</a></li><li><a class="nounderline abstract_t">Holmes CB, Wood R, Badri M, et al. CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr 2006; 42:464.</a></li><li><a class="nounderline abstract_t">Yang Z, Kong Y, Wilson F, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis 2004; 38:199.</a></li><li><a class="nounderline abstract_t">Leeds IL, Magee MJ, Kurbatova EV, et al. Site of extrapulmonary tuberculosis is associated with HIV infection. Clin Infect Dis 2012; 55:75.</a></li><li><a class="nounderline abstract_t">Naing C, Mak JW, Maung M, et al. Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis. Lung 2013; 191:27.</a></li><li><a class="nounderline abstract_t">von Reyn CF, Kimambo S, Mtei L, et al. Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality. Int J Tuberc Lung Dis 2011; 15:1087.</a></li><li><a class="nounderline abstract_t">Shafer RW, Kim DS, Weiss JP, Quale JM. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 1991; 70:384.</a></li><li><a class="nounderline abstract_t">Hudson CP, Wood R, Maartens G. Diagnosing HIV-associated tuberculosis: reducing costs and diagnostic delay. Int J Tuberc Lung Dis 2000; 4:240.</a></li><li><a class="nounderline abstract_t">Frye MD, Pozsik CJ, Sahn SA. Tuberculous pleurisy is more common in AIDS than in non-AIDS patients with tuberculosis. Chest 1997; 112:393.</a></li><li><a class="nounderline abstract_t">Ansari NA, Kombe AH, Kenyon TA, et al. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis 2002; 6:55.</a></li><li><a class="nounderline abstract_t">Mtei L, Matee M, Herfort O, et al. High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis 2005; 40:1500.</a></li><li><a class="nounderline abstract_t">Rangaka MX, Wilkinson RJ, Glynn JR, et al. Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. Clin Infect Dis 2012; 55:1698.</a></li><li><a class="nounderline abstract_t">Chou SH, Prabhu SJ, Crothers K, et al. Thoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings. Radiographics 2014; 34:895.</a></li><li><a class="nounderline abstract_t">Keiper MD, Beumont M, Elshami A, et al. CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection. Chest 1995; 107:74.</a></li><li><a class="nounderline abstract_t">Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161:1376.</a></li><li><a class="nounderline abstract_t">Lessnau KD, Gorla M, Talavera W. Radiographic findings in HIV-positive patients with sensitive and resistant tuberculosis. Chest 1994; 106:687.</a></li><li><a class="nounderline abstract_t">Perlman DC, el-Sadr WM, Nelson ET, et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). Clin Infect Dis 1997; 25:242.</a></li><li><a class="nounderline abstract_t">Padyana M, Bhat RV, Dinesha M, Nawaz A. HIV-Tuberculosis: A Study of Chest X-Ray Patterns in Relation to CD4 Count. N Am J Med Sci 2012; 4:221.</a></li><li><a class="nounderline abstract_t">Johnston H, Reisz G. Changing spectrum of hemoptysis. Underlying causes in 148 patients undergoing diagnostic flexible fiberoptic bronchoscopy. Arch Intern Med 1989; 149:1666.</a></li><li><a class="nounderline abstract_t">McGuinness G, Beacher JR, Harkin TJ, et al. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest 1994; 105:1155.</a></li><li><a class="nounderline abstract_t">Conlan AA, Hurwitz SS, Krige L, et al. Massive hemoptysis. Review of 123 cases. J Thorac Cardiovasc Surg 1983; 85:120.</a></li><li><a class="nounderline abstract_t">Middleton JR, Sen P, Lange M, et al. Death-producing hemoptysis in tuberculosis. Chest 1977; 72:601.</a></li><li><a class="nounderline abstract_t">Knott-Craig CJ, Oostuizen JG, Rossouw G, et al. Management and prognosis of massive hemoptysis. Recent experience with 120 patients. J Thorac Cardiovasc Surg 1993; 105:394.</a></li><li><a class="nounderline abstract_t">Rasmussen V, Moore WD. Continued observations on hemoptysis. Edinburgh Med J 1869; 15:97.</a></li><li><a class="nounderline abstract_t">THOMPSON JR. Mechanisms of fatal pulmonary hemorrhage in tuberculosis. Am J Surg 1955; 89:637.</a></li><li><a class="nounderline abstract_t">Ramakantan R, Bandekar VG, Gandhi MS, et al. Massive hemoptysis due to pulmonary tuberculosis: control with bronchial artery embolization. Radiology 1996; 200:691.</a></li><li><a class="nounderline abstract_t">Muthuswamy PP, Akbik F, Franklin C, et al. Management of major or massive hemoptysis in active pulmonary tuberculosis by bronchial arterial embolization. Chest 1987; 92:77.</a></li><li><a class="nounderline abstract_t">Corey R, Hla KM. Major and massive hemoptysis: reassessment of conservative management. Am J Med Sci 1987; 294:301.</a></li><li><a class="nounderline abstract_t">Uflacker R, Kaemmerer A, Picon PD, et al. Bronchial artery embolization in the management of hemoptysis: technical aspects and long-term results. Radiology 1985; 157:637.</a></li><li><a class="nounderline abstract_t">Jean-Baptiste E. Clinical assessment and management of massive hemoptysis. Crit Care Med 2000; 28:1642.</a></li><li><a class="nounderline abstract_t">Bobrowitz ID, Ramakrishna S, Shim YS. Comparison of medical v surgical treatment of major hemoptysis. Arch Intern Med 1983; 143:1343.</a></li><li><a class="nounderline abstract_t">Yeoh CB, Hubaytar RT, Ford JM, Wylie RH. Treatment of massive hemorrhage in pulmonary tuberculosis. J Thorac Cardiovasc Surg 1967; 54:503.</a></li><li><a class="nounderline abstract_t">Amirana M, Frater R, Tirschwell P, et al. An aggressive surgical approach to significant hemoptysis in patients with pulmonary tuberculosis. Am Rev Respir Dis 1968; 97:187.</a></li><li><a class="nounderline abstract_t">Berry FB. Tuberculous pyopneumothorax with pyogenic infection. J Thorac Surg 1932; 2:139.</a></li><li><a class="nounderline abstract_t">WILDER RJ, BEACHAM EG, RAVITCH MM. Spontaneous pneumothorax complicating cavitary tuberculosis. J Thorac Cardiovasc Surg 1962; 43:561.</a></li><li><a class="nounderline abstract_t">Ihm HJ, Hankins JR, Miller JE, McLaughlin JS. Pneumothorax associated with pulmonary tuberculosis. J Thorac Cardiovasc Surg 1972; 64:211.</a></li><li><a class="nounderline abstract_t">Aktoğu S, Yorgancioglu A, Cirak K, et al. Clinical spectrum of pulmonary and pleural tuberculosis: a report of 5,480 cases. Eur Respir J 1996; 9:2031.</a></li><li><a class="nounderline abstract_t">Hussain SF, Aziz A, Fatima H. Pneumothorax: a review of 146 adult cases admitted at a university teaching hospital in Pakistan. J Pak Med Assoc 1999; 49:243.</a></li><li><a class="nounderline abstract_t">Auerbach O, Lipstein S. Bronchopleural fistulas complication pulmonary tuberculosis. J Thorac Surg 1939; 8:384.</a></li><li><a class="nounderline abstract_t">Rilance AB, Gerstl B. Bronchiectasis secondary to puomonary tuberculosis. Am Rev Tuberc 1943; 48:8.</a></li><li><a class="nounderline abstract_t">Roberts JC, Blair LG. Bronchiectasis in primary tuberculosis. Lancet 1950; 1:386.</a></li><li><a class="nounderline abstract_t">Rosenzweig DY, Stead WW. The role of tuberculosis and other forms of bronchopulmonary necrosis in the pathogenesis of bronchiectasis. Am Rev Respir Dis 1966; 93:769.</a></li><li><a class="nounderline abstract_t">COHEN AG. Atelectasis of the right middle lobe resulting from perforation of tuberculous lymph nodes into bronchi in adults. Ann Intern Med 1951; 35:820.</a></li><li><a class="nounderline abstract_t">CURTIS JK. The significance of bronchiectasis associated with pulmonary tuberculosis. Am J Med 1957; 22:894.</a></li><li><a class="nounderline abstract_t">Brock RC. Post-tuberculous broncho-stenosis and bronchiectasis of the middle lobe. Thorax 1950; 5:5.</a></li><li><a class="nounderline abstract_t">Galdermans D, Verhaert J, Van Meerbeeck J, et al. Broncholithiasis: present clinical spectrum. Respir Med 1990; 84:155.</a></li><li><a class="nounderline abstract_t">Bobrowitz ID, Rodescu D, Marcus H, Abeles H. The destroyed tuberculous lung. Scand J Respir Dis 1974; 55:82.</a></li><li><a class="nounderline abstract_t">Palmer PE. Pulmonary tuberculosis--usual and unusual radiographic presentations. Semin Roentgenol 1979; 14:204.</a></li><li><a class="nounderline abstract_t">Khan FA, Rehman M, Marcus P, Azueta V. Pulmonary gangrene occurring as a complication of pulmonary tuberculosis. Chest 1980; 77:76.</a></li><li><a class="nounderline abstract_t">López-Contreras J, Ris J, Domingo P, et al. Tuberculous pulmonary gangrene: report of a case and review. Clin Infect Dis 1994; 18:243.</a></li><li><a class="nounderline abstract_t">Sudarsan TI, Thomas L, Samprathi A, et al. Tuberculous ARDS is associated with worse outcome when compared with non-tuberculous infectious ARDS. J Crit Care 2021; 61:138.</a></li><li><a class="nounderline abstract_t">Kethireddy S, Light RB, Mirzanejad Y, et al. Mycobacterium tuberculosis septic shock. Chest 2013; 144:474.</a></li><li><a class="nounderline abstract_t">Brenner AV, Wang Z, Kleinerman RA, et al. Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int J Epidemiol 2001; 30:118.</a></li><li><a class="nounderline abstract_t">Liang HY, Li XL, Yu XS, et al. Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer 2009; 125:2936.</a></li><li><a class="nounderline abstract_t">Falagas ME, Kouranos VD, Athanassa Z, Kopterides P. Tuberculosis and malignancy. QJM 2010; 103:461.</a></li><li><a class="nounderline abstract_t">Danwang C, Bigna JJ, Awana AP, et al. Global epidemiology of venous thromboembolism in people with active tuberculosis: a systematic review and meta-analysis. J Thromb Thrombolysis 2021; 51:502.</a></li></ol></div><div id="topicVersionRevision">Topic 7026 Version 40.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33761302" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Latent Tuberculosis: Two Centuries of Confusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24754048" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Early clearance of Mycobacterium tuberculosis: a new frontier in prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5638222" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The epidemiology of tuberculosis infection in a closed environment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31508399" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Immune Response to Mycobacterium tuberculosis: A Narrative Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17848689" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Tuberculosis: a radiologic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33321506" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Anton Ghon and His Colleagues and Their Studies of the Primary Focus and Complex of Tuberculosis Infection and Their Relevance for the Twenty-First Century.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25809762" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Imaging in tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7073104" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Epidemiology of tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7073104" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Epidemiology of tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25265362" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1640920" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : National action plan to combat multidrug-resistant tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21488766" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Clinical practice. Latent tuberculosis infection in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17325294" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25605864" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Cigarette smoking and pulmonary tuberculosis in northern California.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The infection of tuberculosis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22267721" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5642961" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The clinical spectrum of primary tuberculosis in adults. Confusion with reinfection in the pathogenesis of chronic tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2182901" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Radiologic manifestations of adult tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13424392" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Some clinical features of tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6867325" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Adult-onset pulmonary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8149264" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Radiologic features of pulmonary tuberculosis: an assessment of 188 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/835590" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Clinical and roentgenographic spectrum of pulmonary tuberculosis in the adult.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3484866" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Update: the radiographic features of pulmonary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18716117" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Pulmonary tuberculosis: up-to-date imaging and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8456658" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Adult-onset pulmonary tuberculosis: findings on chest radiographs and CT scans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15671390" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Pulmonary tuberculosis: another disease showing clusters of small nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2456183" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Chest roentgenogram in pulmonary tuberculosis. New data on an old test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4741875" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The spectrum of tuberculosis as currently seen in a metropolitan hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1115069" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A year's experience with tuberculosis in a private urban teaching hospital in the postsanatorium era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/817877" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Diagnosis, prevention and early therapy of tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11336272" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Screening for pulmonary tuberculosis among immigrants: estimated effect on severity of disease and duration of infectiousness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10671331" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : A population-based survey of tuberculosis symptoms: how atypical are atypical presentations?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33602715" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Incidence, duration and risk factors associated with delayed and missed diagnostic opportunities related to tuberculosis: a population-based longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24717600" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Impact of diabetes on clinical presentation and treatment outcome of pulmonary tuberculosis in Beijing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36441785" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11850859" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16973982" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10531160" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Does aging modify pulmonary tuberculosis?: A meta-analytical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8297197" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Delayed diagnosis of pulmonary tuberculosis in city hospitals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7072745" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Active tuberculosis undiagnosed until autopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18173876" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : How good are systemic symptoms and blood inflammatory markers at detecting individuals with tuberculosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20051406" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Hyponatremia in pulmonary TB: evidence of ectopic antidiuretic hormone production.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16704034" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13498472" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Segmentary distribution of cavities; a radiologic study of 500 consecutive cases of cavernous pulmonary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3940794" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Initial roentgenographic manifestations of bacteriologically proven Mycobacterium tuberculosis. Typical or atypical?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13424827" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Segmental localization of upper lobe tuberculosis; the rarity of anterior involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28076011" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Pulmonary Tuberculosis: Role of Radiology in Diagnosis and Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/417585" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Tuberculosis: frequency of unusual radiographic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10027446" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Detection of pulmonary tuberculosis in patients with a normal chest radiograph.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8430169" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Pulmonary tuberculosis: CT findings--early active disease and sequential change with antituberculous therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28473072" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : ACR Appropriateness Criteria®Imaging of Possible Tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8527173" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : CT of pulmonary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7991884" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Endobronchial tuberculosis: diagnostic features and therapeutic outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The natural history of tuberculous tracheobronchitis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Bronchoscopic observations in tuberculosis tracheobronchitis: Clinical and pathological correlations</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15403805" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Bronchoscopy in a sanatorium; a review of 522 consecutive bronchoscopies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15392764" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Tuberculosis of the trachea and major bronchi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28203440" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Tracheobronchial tuberculosis: a clinical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9434324" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Endobronchial tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12962459" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Endobronchial tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10669679" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Bronchoscopic assessment of the evolution of endobronchial tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25620110" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Incidence and clinical predictors of endobronchial tuberculosis in patients with pulmonary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13340182" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The course and prognosis of endobronchial tuberculosis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Lymph node perforation through the bronchial tree in children with primary tuberculosis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1395814" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Endobronchial tuberculosis. Clinical and bronchoscopic features in 121 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3698702" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Endobronchial tuberculosis revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6780181" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Endobronchial tuberculosis and its sequelae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2707079" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Endobronchial tuberculosis simulating foreign body aspiration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6478910" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Endobronchial tuberculosis simulating lung cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2121113" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Clinical spectrum of endobronchial tuberculosis in elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6628019" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Bronchorrhea. A presenting feature of active endobronchial tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3349843" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Endobronchial tuberculosis presenting as asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8733492" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : High resolution computed tomographic findings in pulmonary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28149579" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Endobronchial tuberculosis-a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/975957" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Endobronchial tuberculosis progressing to bronchial stenosis. Fiberoptic bronchoscopic manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13987682" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Lower lung field tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3802933" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Lower lung field tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4951912" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Lower lung field tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14044162" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : THE SOLITARY PULMONARY NODULE. REPORT OF A COOPERATIVE STUDY OF RESECTED ASYMPTOMATIC SOLITARY PULMONARY NODULES IN MALES.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7235393" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Tuberculosis among elderly persons: an outbreak in a nursing home.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/112687" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Pathology of tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2014294" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15065838" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Response of pulmonary tuberculomas to anti-tuberculous treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11485587" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Epidemiological considerations and clinical features of ENT tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30251032" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Primary Laryngeal Tuberculosis: A Series of 15 Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24628484" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Laryngeal tuberculosis in the United States of America: a forgotten disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27077734" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Factors Associated with Clinical and Topographical Features of Laryngeal Tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : A clinical study on laryngeal manifestations of tuberculosis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7916467" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2030721" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Tuberculosis in patients with human immunodeficiency virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29382589" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : The prevalence and determinants of active tuberculosis among diabetes patients in Cape Town, South Africa, a high HIV/TB burden setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7902049" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16810113" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14699451" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Identification of risk factors for extrapulmonary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22423123" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Site of extrapulmonary tuberculosis is associated with HIV infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23180033" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21740673" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1956280" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10751070" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Diagnosing HIV-associated tuberculosis: reducing costs and diagnostic delay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9266874" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Tuberculous pleurisy is more common in AIDS than in non-AIDS patients with tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11931402" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15844073" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22955441" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25019430" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Thoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7813316" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10764337" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8082339" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Radiographic findings in HIV-positive patients with sensitive and resistant tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9332519" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22655281" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : HIV-Tuberculosis: A Study of Chest X-Ray Patterns in Relation to CD4 Count.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2742442" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Changing spectrum of hemoptysis. Underlying causes in 148 patients undergoing diagnostic flexible fiberoptic bronchoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8162743" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Hemoptysis: prospective high-resolution CT/bronchoscopic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6848880" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Massive hemoptysis. Review of 123 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/913138" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Death-producing hemoptysis in tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8445918" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Management and prognosis of massive hemoptysis. Recent experience with 120 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Continued observations on hemoptysis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13228824" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Mechanisms of fatal pulmonary hemorrhage in tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8756916" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Massive hemoptysis due to pulmonary tuberculosis: control with bronchial artery embolization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2439259" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Management of major or massive hemoptysis in active pulmonary tuberculosis by bronchial arterial embolization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3425580" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Major and massive hemoptysis: reassessment of conservative management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4059552" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Bronchial artery embolization in the management of hemoptysis: technical aspects and long-term results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10834728" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Clinical assessment and management of massive hemoptysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6870407" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Comparison of medical v surgical treatment of major hemoptysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6051437" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Treatment of massive hemorrhage in pulmonary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5637935" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : An aggressive surgical approach to significant hemoptysis in patients with pulmonary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Tuberculous pyopneumothorax with pyogenic infection</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14006972" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Spontaneous pneumothorax complicating cavitary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5048375" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Pneumothorax associated with pulmonary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8902463" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Clinical spectrum of pulmonary and pleural tuberculosis: a report of 5,480 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10647229" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Pneumothorax: a review of 146 adult cases admitted at a university teaching hospital in Pakistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Bronchopleural fistulas complication pulmonary tuberculosis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Bronchiectasis secondary to puomonary tuberculosis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Bronchiectasis in primary tuberculosis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5296012" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : The role of tuberculosis and other forms of bronchopulmonary necrosis in the pathogenesis of bronchiectasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14878325" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Atelectasis of the right middle lobe resulting from perforation of tuberculous lymph nodes into bronchi in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13424554" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : The significance of bronchiectasis associated with pulmonary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Post-tuberculous broncho-stenosis and bronchiectasis of the middle lobe</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2371439" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Broncholithiasis: present clinical spectrum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4854707" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : The destroyed tuberculous lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/472765" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Pulmonary tuberculosis--usual and unusual radiographic presentations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7351153" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Pulmonary gangrene occurring as a complication of pulmonary tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8161634" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Tuberculous pulmonary gangrene: report of a case and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33161242" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Tuberculous ARDS is associated with worse outcome when compared with non-tuberculous infectious ARDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23429859" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Mycobacterium tuberculosis septic shock.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11171871" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Previous pulmonary diseases and risk of lung cancer in Gansu Province, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19521963" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20504861" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Tuberculosis and malignancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32627124" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Global epidemiology of venous thromboembolism in people with active tuberculosis: a systematic review and meta-analysis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
